SCHIERMEIER ANDREW
Insider CIK 1738456 · NTLA EVP, Dev and Corp Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 13,125 | — | $0 | 13,125 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 78,750 | — | $0 | 78,750 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-01-05 | 2021-01-05 | 1,377 | $55.86 | $76.9K | 16,656 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 4,792 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-12-31 | 2021-01-05 | 9,583 | — | $0 | 9,583 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 18,033 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-30 | 2021-01-04 | 1,500 | — | $0 | 148,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-30 | 2021-01-04 | 1,500 | $13.48 | $20.2K | 12,673 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-03-02 | 2020-03-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-01-03 | 2020-03-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-08-01 | 2019-08-02 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2019-03-06 | 2019-03-12 | 4,250 | $15.50 | $65.9K | 7,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2019-03-06 | 2019-03-12 | 3,250 | $16.00 | $52.0K | 3,250 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-12-18 | 2018-12-20 | 81,000 | — | $0 | 81,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-05-01 | 2018-05-02 | 23,500 | — | $0 | 23,500 | SEC↗ |